Description

The Participant assumes the role of UK General Manager of a pharmaceutical company.  They have received reports of a number of cases in which packs of their medicines have been incorrectly labelled. They have informed the Regulatory Authorities, who have requested an immediate meeting.

The Participant is given background information regarding the extent and likely cause of the problem, as well as some possible ways of ensuring a repetition and also cost and profitability information.

Their task is to meet with the Regulator to explain what has happened. They must also agree an action plan to deal with the problem and to guarantee patient safety in the future. They must also try to limit the damage to the company’s reputation.

To place an order or discuss your needs further, call us or email customersupport@adc.uk.com